Nutritional Supplementation in Geriatric Hip Fractures

Description

This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The main question it aims to answer is: - Does supplementation decrease muscle loss via ultrasound measurements of the cross-sectional area of the rectus femoris of the uninjured leg?

Conditions

Geriatric Hip Fracture

Study Overview

Study Details

Study overview

This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The main question it aims to answer is: - Does supplementation decrease muscle loss via ultrasound measurements of the cross-sectional area of the rectus femoris of the uninjured leg?

Can Complex Carbohydrates and Essential Amino Acid Supplementation Improve Outcomes Following Geriatric Hip Fractures

Nutritional Supplementation in Geriatric Hip Fractures

Condition
Geriatric Hip Fracture
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Male or female, aged 65 years or older.
  • 2. Presenting with a geriatric hip fracture (femoral neck, intertrochanteric, or subtrochanteric) requiring surgical intervention.
  • 3. Able to provide informed consent.
  • 4. Expected to survive at least 6 months after surgery, with no terminal illness.
  • 1. Pre-existing conditions that significantly impair mobility prior to injury.
  • 2. Severe renal or liver impairment.
  • 3. Active treatment with investigational drugs or participation in another clinical trial within the last 30 days.
  • 4. Inability to tolerate oral nutritional supplementation due to gastrointestinal disorders.
  • 5. Allergies to any components of the nutritional supplement being tested.

Ages Eligible for Study

65 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Abhishek Ganta, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2027-06-30